Montelukast Sodium
Product Images NDC 53002-5441

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 53002-5441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (18422beb 7f97 43aa 8f64 1d30aa8b07f7 907 2)

FDA Label Image

Figure 1 (57f07f65 1a14 4423 9da8 975664ca0684 01)

Figure 1 (57f07f65 1a14 4423 9da8 975664ca0684 01)
A line graph depicting change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo. The x-axis represents weeks on treatment, while the y-axis shows change in height. Data points show growth trends from baseline to week 56.*
FDA Label Image

Structure (57f07f65 1a14 4423 9da8 975664ca0684 02)

Structure (57f07f65 1a14 4423 9da8 975664ca0684 02)
Chemical structure diagram of montelukast sodium, showing its molecular arrangement including aromatic rings, sodium carboxylate group, and other functional groups.*
FDA Label Image

Figure 2 (57f07f65 1a14 4423 9da8 975664ca0684 03)

Figure 2 (57f07f65 1a14 4423 9da8 975664ca0684 03)
A line graph comparing mean percent change from baseline over 15 weeks in two groups: placebo and montelukast sodium. The x-axis represents weeks in treatment, and the y-axis shows mean percent change from baseline. Montelukast sodium demonstrates a higher increase compared to placebo, with values peaking around week 12 before a decline during the washout period.*
FDA Label Image

Label Image (Lbl530025441)

Label Image (Lbl530025441)
Montelukast Sodium 10 mg Tablets carton label from RPK Pharmaceuticals, Inc. The label specifies the medication as unchewable tablets, with a dosage of one tablet daily. It includes administrative sections for patient and prescribing information, directions, and clinic name. The packaging contains 30 tablets and features multiple NDC codes for billing and identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.